Reducing radiation during heart catheter procedures
Part of Injuries & trauma clinical trials.
This trial tests a new way to reduce the amount of radiation you receive during a heart procedure (like angioplasty or stenting) done through the wrist. It aims to make the procedure safer for patients and staff.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled to have a coronary procedure (like angioplasty or stenting) in the catheter lab.
- The procedure will be done through the wrist (right or left radial artery), not the groin.
- You are not pregnant.
- You are able to understand and give your own consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares radiation exposure to doctors performing heart procedures using two different arm access points. It helps determine which approach is safer for medical staff doing these procedures repeatedly.
This trial is for the interventional care team, not patients, testing a device that may reduce radiation exposure during planned leg artery procedures.
This study compares usual radiation dose with a lower dose during routine heart catheterizations (diagnostic angiograms) for people whose heart arteries turn out to be normal. It aims to see if lower-dose imaging still provides good pictures while reducing radiation exposure.
This study tests a new way to use less radiation during a heart catheter procedure (coronary angiography). The goal is to see if it's safe and effective.
This study compares two ways doctors can reach the heart during a catheter procedure: through the wrist (radial) or the groin (femoral). It aims to reduce bleeding and access-site complications, especially when patients may need a balloon/stent (PCI).
This trial tests whether a new wrist access point (the distal radial artery) along with specific drug treatments (CAG and PCI) is safe and effective for people with small blood vessels in the heart. It aims to offer an alternative that may reduce bleeding or damage risks.
Hear when a new Radiation Exposure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.